ImmunityBio at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
ImmunityBio at ESMO 2026 in Madrid: Booth 8112.
| Organization | ESMO 2026 Attendance |
|---|---|
US immunotherapy company whose IL-15 agonist Anktiva is approved for non-muscle-invasive bladder cancer. | Booth Exhibiting at Booth 8112 |
Instantly find 20 buyers from ImmunityBio
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction